Sibannac, Inc.
corporate_fare Company Profile
Sibannac, Inc. (OTC:SNNC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for SNNC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-20, rated 7/10. Across its 4 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above.
Recent high-impact activity:
- Sibannac Expands Wellness Portfolio with New Functional Mushroom and Moringa Products
- Sibannac Forms Joint Venture to Develop DEA-Compliant Psilocybin Research Facility
- Presidential Executive Order Expected to Fuel Psychedelic Tourism Surge, Benefiting Sibannac
- Sibannac (SNNC) Taps Small Cap Access for Revenue & Liquidity Drive
Financial Snapshot
Short Interest & Short Volume
On October 1, 2026, 82.4% of SNNC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.